Human disorders of peroxisome metabolism and biogenesis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 5, 2016, Pages 922-933

  Waterham, Hans R ^a   Ferdinandusse, Sacha ^a   Wanders, Ronald J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biogenesis; Enzyme deficiencies; Metabolism; Peroxisomes; PEX genes; Zellweger spectrum disorders

Indexed keywords

BILE ACID; DOCOSAHEXAENOIC ACID; ENZYME; ETHER PHOSPHOLIPID; FATTY ACID; G PROTEIN COUPLED RECEPTOR 40; GLYOXYLIC ACID; ISOPROTEIN; MEMBRANE PROTEIN; PEX1 PROTEIN, HUMAN; PLASMALOGEN; SIGNAL PEPTIDE;

ADRENOLEUKODYSTROPHY; ARTICLE; BILE ACID SYNTHESIS; CATALASE DEFICIENCY; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; DETOXIFICATION; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME DEFICIENCY; GENE MUTATION; GENETIC DISORDER; HUMAN; NONHUMAN; ORGANELLE BIOGENESIS; OXIDATION; PEROXISOME; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ZELLWEGER SYNDROME; CHEMISTRY; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

FATTY ACIDS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MUTATION; ORGANELLE BIOGENESIS; OXIDATION-REDUCTION; PEROXISOMAL DISORDERS; PEROXISOMES; PLASMALOGENS; PROTEIN ISOFORMS; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84961122547     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.11.015     Document Type: Article

References (174)

1. Wanders R.J.A., Waterham H.R. Biochemistry of mamalian peroxisomes revisited. Annu. Rev. Biochem. 2006, 75:295-332.
2. Ashmarina L.I., Pshezhetsky A.V., Branda S.S., Isaya G., Mitchell G.A. 3-hydroxy-3-methylglutaryl coenzyme A lyase: targeting and processing in peroxisomes and mitochondria. J. Lipid Res. 1999, 40:70-75.
3. Ashmarina L.I., Robert M.F., Elsliger M.A., Mitchell G.A. Characterization of the hydroxymethylglutaryl-CoA lyase precursor, a protein targeted to peroxisomes and mitochondria. Biochem. J. 1996, 315(Pt 1):71-75.
4. Kotti T.J., Savolainen K., Helander H.M., Yagi A., Novikov D.K., Kalkkinen N., Conzelmann E., Hiltunen J.K., Schmitz W. In mouse alpha-methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes. J. Biol. Chem. 2000, 275:20887-20895.
5. Ferdinandusse S., Denis S., L I.J., Dacremont G., Waterham H.R., Wanders R.J. subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J. Lipid Res. 1890-1896, 41(2000).
6. Amery L., Fransen M., De Nys K., Mannaerts G.P., Van Veldhoven P.P. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J. Lipid Res. 2000, 41:1752-1759.
7. Wanders R.J.A. Defects in mitochondrial and peroxisomal fatty acid oxidation. Lipobiology 2004, 295-317. Elsevier, Amsterdam-Tokyo. G. van der Vusse (Ed.).
8. Wanders R.J.A., Ferdinandusse S., Brites P., Kemp S. Peroxisomes, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 2010, 1801:272-280.
9. Van Veldhoven P.P. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J. Lipid Res. 2010, 51:2863-2895.
10. Jansen G.A., Wanders R.J.A. Alpha-oxidation. Biochim. Biophys. Acta 2006, 1763:1403-1412.
11. Wanders R.J.A., Jansen G.A., Lloyd M.D. Phytanic acid alpha-oxidation, new insights into an old problem: a review. Biochim. Biophys. Acta 2003, 1631:119-135.
12. Wanders R.J.A., Komen J.C., Ferdinandusse S. Phytanic acid metabolism in health and disease. Biochim. Biophys. Acta 2011, 1811:498-507.
13. Salido E., Pey A.L., Rodriguez R., Lorenzo V. Primary hyperoxalurias: disorders of glyoxylate detoxification. Biochim. Biophys. Acta 2012, 1822:1453-1464.
14. Braverman N.E., Moser A.B. Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 2012, 1822:1442-1452.
15. Brites P., Waterham H.R., Wanders R.J. Functions and biosynthesis of plasmalogens in health and disease. Biochim. Biophys. Acta 2004, 1636:219-231.
16. Buchert R., Tawamie H., Smith C., Uebe S., Innes A.M., Al Hallak B., Ekici A.B., Sticht H., Schwarze B., Lamont R.E., Parboosingh J.S., Bernier F.P., Abou Jamra R. A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am. J. Hum. Genet. 2014, 95:602-610.
17. Clayton P.T. Disorders of bile acid synthesis. J. Inherit. Metab. Dis. 2011, 34:593-604.
18. Ferdinandusse S., Houten S.M. Peroxisomes and bile acid biosynthesis. Biochim. Biophys. Acta 2006, 1763:1427-1440.
19. Heubi J.E., Setchell K.D., Bove K.E. Inborn errors of bile acid metabolism. Semin. Liver Dis. 2007, 27:282-294.
20. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
21. Wanders R.J.A., van Grunsven E.G., Jansen G.A. Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans. Biochem. Soc. Trans. 2000, 28:141-149.
22. Ferdinandusse S., Denis S., Mooijer P.A., Zhang Z., Reddy J.K., Spector A.A., Wanders R.J.A. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J. Lipid Res. 2001, 42:1987-1995.
23. Wallner S., Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem. Phys. Lipids 2011, 164:573-589.
24. Bonekamp N.A., Volkl A., Fahimi H.D., Schrader M. Reactive oxygen species and peroxisomes: struggling for balance. BioFactors 2009, 35:346-355. (Oxford, England).
25. Angermuller S., Bruder G., Volkl A., Wesch H., Fahimi H.D. Localization of xanthine oxidase in crystalline cores of peroxisomes. A cytochemical and biochemical study. Eur. J. Cell. Biol. 1987, 45:137-144.
26. del Rio L.A., Corpas F.J., Sandalio L.M., Palma J.M., Gomez M., Barroso J.B. Reactive oxygen species, antioxidant systems and nitric oxide in peroxisomes. J. Exp. Bot. 2002, 53:1255-1272.
27. Wanders R.J.A., Denis S. Identification of superoxide dismutase in rat liver peroxisomes. Biochim. Biophys. Acta 1992, 1115:259-262.
28. Stolz D.B., Zamora R., Vodovotz Y., Loughran P.A., Billiar T.R., Kim Y.M., Simmons R.L., Watkins S.C. Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 2002, 36:81-93.
29. Islinger M., Li K.W., Seitz J., Volkl A., Luers G.H. Hitchhiking of Cu/Zn superoxide dismutase to peroxisomes-evidence for a natural piggyback import mechanism in mammals. Traffic 2009, 10:1711-1721.
30. Yamashita H., Avraham S., Jiang S., London R., Van Veldhoven P.P., Subramani S., Rogers R.A., Avraham H. Characterization of human and murine PMP20 peroxisomal proteins that exhibit antioxidant activity in vitro. J. Biol. Chem. 1999, 274:29897-29904.
31. Lismont C., Nordgren M., Van Veldhoven P.P., Fransen M. Redox interplay between mitochondria and peroxisomes. Front. Cell Dev. Biol. 2015, 3:35.
32. Fujiki Y., Okumoto K., Mukai S., Honsho M., Tamura S. Peroxisome biogenesis in mammalian cells. Front. Physiol. 2014, 5:307.
33. Smith J.J., Aitchison J.D. Peroxisomes take shape. Nat. Rev. Mol. Cell Biol. 2013, 14:803-817.
34. Steinberg S.J., Dodt G., Raymond G.V., Braverman N.E., Moser A.B., Moser H.W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 2006, 1763:1733-1748.
35. Waterham H.R., Ebberink M.S. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim. Biophys. Acta 2012, 1822:1430-1441.
36. Weller S., Gould S.J., Valle D. Peroxisome biogenesis disorders. Annu. Rev. Genomics Hum. Genet. 2003, 4:165-211.
37. Schrader M., Bonekamp N.A., Islinger M. Fission and proliferation of peroxisomes. Biochim. Biophys. Acta 2012, 1822:1343-1357.
38. Schrader M., Fahimi H.D. Growth and division of peroxisomes. Int. Rev. Cytol. 2006, 255:237-290.
39. Dimitrov L., Lam S.K., Schekman R. The role of the endoplasmic reticulum in peroxisome biogenesis. Cold Spring Harb. Perspect. Biol. 2013, 5:a013243.
40. Ma C., Agrawal G., Subramani S. Peroxisome assembly: matrix and membrane protein biogenesis. J. Cell Biol. 2011, 193:7-16.
41. Agrawal G., Subramani S. Emerging role of the endoplasmic reticulum in peroxisome biogenesis. Front. Physiol. 2013, 4:286.
42. Kim P.K., Mullen R.T., Schumann U., Lippincott-Schwartz J. The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER. J. Cell Biol. 2006, 173:521-532.
43. Jones J.M., Morrell J.C., Gould S.J. PEX19 is a predominantly cytosolic chaperone and import receptor for class 1 peroxisomal membrane proteins. J. Cell Biol. 2004, 164:57-67.
44. Rottensteiner H., Kramer A., Lorenzen S., Stein K., Landgraf C., Volkmer-Engert R., Erdmann R. Peroxisomal membrane proteins contain common Pex19p-binding sites that are an integral part of their targeting signals. Mol. Biol. Cell 2004, 15:3406-3417.
45. Jones J.M., Morrell J.C., Gould S.J. Multiple distinct targeting signals in integral peroxisomal membrane proteins. J. Cell Biol. 2001, 153:1141-1150.
46. Fang Y., Morrell J.C., Jones J.M., Gould S.J. PEX3 functions as a PEX19 docking factor in the import of class I peroxisomal membrane proteins. J. Cell Biol. 2004, 164:863-875.
47. Fang Y., Morrell J.C., Jones J.M., Gould S.J. PEX3 functions as a PEX19 docking factor in the import of class I peroxisomal membrane proteins. J. Cell Biol. 2004, 164:863-875.
48. Fujiki Y. Peroxisome biogenesis and peroxisome biogenesis disorders. FEBS Lett. 2000, 476:42-46.
49. Fujiki Y., Matsuzono Y., Matsuzaki T., Fransen M. Import of peroxisomal membrane proteins: the interplay of Pex3p- and Pex19p-mediated interactions. Biochim. Biophys. Acta 2006, 1763:1639-1646.
50. Honsho M., Hiroshige T., Fujiki Y. The membrane biogenesis peroxin Pex16p. Topogenesis and functional roles in peroxisomal membrane assembly. J. Biol. Chem. 2002, 277:44513-44524.
51. Lazarow P.B. The import receptor Pex7p and the PTS2 targeting sequence. Biochim. Biophys. Acta 2006, 1763:1599-1604.
52. Subramani S. Targeting of proteins into the peroxisomal matrix. J. Membr. Biol. 1992, 125:99-106.
53. Braverman N., Dodt G., Gould S.J., Valle D. An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. Hum. Mol. Genet. 1998, 7:1195-1205.
54. Dodt G., Warren D., Becker E., Rehling P., Gould S.J. Domain mapping of human PEX5 reveals functional and structural similarities to Saccharomyces cerevisiae Pex18p and Pex21p. J. Biol. Chem. 2001, 276:41769-41781.
55. Dammai V., Subramani S. The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol. Cell 2001, 105:187-196.
56. Dodt G., Gould S.J. Multiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptor. J. Cell Biol. 1996, 135:1763-1774.
57. Chang C.C., Warren D.S., Sacksteder K.A., Gould S.J. PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J. Cell Biol. 1999, 147:761-774.
58. Azevedo J.E., Costa-Rodrigues J., Guimaraes C.P., Oliveira M.E., Sa-Miranda C. Protein translocation across the peroxisomal membrane. Cell Biochem. Biophys. 2004, 41:451-468.
59. Carvalho A.F., Pinto M.P., Grou C.P., Alencastre I.S., Fransen M., Sa-Miranda C., Azevedo J.E. Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J. Biol. Chem. 2007, 282:31267-31272.
60. Grou C.P., Carvalho A.F., Pinto M.P., Alencastre I.S., Rodrigues T.A., Freitas M.O., Francisco T., Sa-Miranda C., Azevedo J.E. The peroxisomal protein import machinery-a case report of transient ubiquitination with a new flavor. Cell. Mol. Life Sci. 2009, 66:254-262.
61. Gouveia A.M., Guimaraes C.P., Oliveira M.E., Reguenga C., Sa-Miranda C., Azevedo J.E. Characterization of the peroxisomal cycling receptor Pex5p import pathway. Adv. Exp. Med. Biol. 2003, 544:219-220.
62. Oliveira M.E., Gouveia A.M., Pinto R.A., Sa-Miranda C., Azevedo J.E. The energetics of Pex5p-mediated peroxisomal protein import. J. Biol. Chem. 2003, 278:39483-39488.
63. van der Zand A., Braakman I., Tabak H.F. Peroxisomal membrane proteins insert into the endoplasmic reticulum. Mol. Biol. Cell 2010, 21:2057-2065.
64. Tabak H.F., Braakman I., van der Zand A. Peroxisome formation and maintenance are dependent on the endoplasmic reticulum. Annu. Rev. Biochem. 2013, 82:723-744.
65. van der Zand A., Tabak H.F. Peroxisomes: offshoots of the ER. Curr. Opin. Cell Biol. 2013, 25:449-454.
66. Schrader M., Costello J., Godinho L.F., Islinger M. Peroxisome-mitochondria interplay and disease. J. Inherit. Metab. Dis. 2015, 38:681-702.
67. Schrader M., Grille S., Fahimi H.D., Islinger M. Peroxisome interactions and cross-talk with other subcellular compartments in animal cells. Subcell. Biochem. 2013, 69:1-22.
68. Opalinski L., Veenhuis M., van der Klei I.J. Peroxisomes: membrane events accompanying peroxisome proliferation. Int. J. Biochem. Cell Biol. 2011, 43:847-851.
69. Thoms S., Erdmann R. Dynamin-related proteins and Pex11 proteins in peroxisome division and proliferation. FEBS J. 2005, 272:5169-5181.
70. Koch J., Brocard C. PEX11 proteins attract Mff and human Fis1 to coordinate peroxisomal fission. J. Cell Sci. 2012, 125:3813-3826.
71. Koch J., Pranjic K., Huber A., Ellinger A., Hartig A., Kragler F., Brocard C. PEX11 family members are membrane elongation factors that coordinate peroxisome proliferation and maintenance. J. Cell Sci. 2010, 123:3389-3400.
72. Opalinski L., Kiel J.A., Williams C., Veenhuis M., van der Klei I.J. Membrane curvature during peroxisome fission requires Pex11. Embo J. 2011, 30:5-16.
73. Li X., Baumgart E., Dong G.X., Morrell J.C., Jimenez-Sanchez G., Valle D., Smith K.D., Gould S.J. PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation. Mol. Cell. Biol. 2002, 22:8226-8240.
74. Ebberink M.S., Koster J., Visser G., van Spronsen F.J., Stolte-Dijkstra I., Smit G.P.A., Fock J.M., Kemp S., Wanders R.J.A., Waterham H.R. A novel human defect of peroxisome division due to a homozygous non-sense mutation in the PEX11 beta gene. J. Med. Genet. 2012, 49:307-313.
75. Li X., Baumgart E., Morrell J.C., Jimenez-Sanchez G., Valle D., Gould S.J. PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol. 2002, 22:4358-4365.
76. Weng H., Ji X., Naito Y., Endo K., Ma X., Takahashi R., Shen C., Hirokawa G., Fukushima Y., Iwai N. Pex11alpha deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E187-E196.
77. Praefcke G.J., McMahon H.T. The dynamin superfamily: universal membrane tubulation and fission molecules?. Nat. Rev. Mol. Cell Biol. 2004, 5:133-147.
78. Williams C., Opalinski L., Landgraf C., Costello J., Schrader M., Krikken A.M., Knoops K., Kram A.M., Volkmer R., van der Klei I.J. The membrane remodeling protein Pex11p activates the GTPase Dnm1p during peroxisomal fission. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:6377-6382.
79. Waterham H.R., Koster J., van Roermund C.W., Mooyer P.A., Wanders R.J., Leonard J.V. A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J. Med. 2007, 356:1736-1741.
80. Koch A., Schneider G., Luers G.H., Schrader M. Peroxisome elongation and constriction but not fission can occur independently of dynamin-like protein 1. J. Cell Sci. 2004, 117:3995-4006.
81. Koch A., Thiemann M., Grabenbauer M., Yoon Y., McNiven M.A., Schrader M. Dynamin-like protein 1 is involved in peroxisomal fission. J. Biol. Chem. 2003, 278:8597-8605.
82. Koch A., Yoon Y., Bonekamp N.A., McNiven M.A., Schrader M. A role for Fis1 in both mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 2005, 16:5077-5086.
83. Kemp S., Berger J., Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim. Biophys. Acta 2012, 1822:1465-1474.
84. Engelen M., Barbier M., Dijkstra I.M., Schur R., de Bie R.M., Verhamme C., Dijkgraaf M.G., Aubourg P.A., Wanders R.J., van Geel B.M., de Visser M., Poll-The B.T., Kemp S. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain 2014, 137:693-706.
85. Engelen M., Kemp S., Poll-The B.T. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr. Neurol. Neurosci. Rep. 2014, 14:486.
86. Wanders R.J.A., Visser W.F., van Roermund C.W., Kemp S., Waterham H.R. The peroxisomal ABC transporter family. Pflugers Arch. 2006, 453:719-734.
87. Morita M., Shimozawa N., Kashiwayama Y., Suzuki Y., Imanaka T. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Curr. Drug Targets 2011, 12:694-706.
88. van Roermund C.W., Ijlst L., Wagemans T., Wanders R.J., Waterham H.R. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochim. Biophys. Acta 2014, 1841:563-568.
89. van Roermund C.W.T., Visser W.F., IJlst L., A.G.v.C., Boek M., Kulik W., Waterham H.R., Wanders R.J.A. the human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 2008, 22:4201-4208.
90. van Roermund C.W.T., Visser W.F., IJlst L., Waterham H.R., Wanders R.J.A. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation. BBA-Mol. Cell. Biol. L. 2011, 1811:148-152.
91. Ofman R., Dijkstra I.M., van Roermund C.W., Burger N., Turkenburg M., van Cruchten A., van Engen C.E., Wanders R.J., Kemp S. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol. Med. 2010, 2:90-97.
92. Schackmann M.J., Ofman R., Dijkstra I.M., Wanders R.J., Kemp S. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim. Biophys. Acta 2015, 1851:231-237.
93. Kemp S., Berger J., Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim. Biophys. Acta 2012, 1822:1465-1474.
94. M. Engelen, S. Kemp, M. de Visser, B.M. van Geel, R.J.A. Wanders, P.A. Aubourg, B.T. Poll-The, X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management, Orphanet J. Rare Dis. 7(2012) 51.
95. Miller W.P., Rothman S.M., Nascene D., Kivisto T., DeFor T.E., Ziegler R.S., Eisengart J., Leiser K., Raymond G., Lund T.C., Tolar J., Orchard P.J. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011, 118:1971-1978.
96. Poll-The B.T., Roels F., Ogier H., Scotto J., Vamecq J., Schutgens R.B.H., Wanders R.J.A., van Roermund C.W.T., van Wijland M.J., Schram A.W., Tager J.M., Saudubray J.M. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am. J. Hum. Genet. 1988, 42:422-434.
97. Ferdinandusse S., Denis S., Hogenhout E.M., Koster J., van Roermund C.W.T., IJlst L., Moser A.B., Wanders R.J.A., Waterham H.R. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum. Mutat. 2007, 28:904-912.
98. Wanders R.J.A., Denis S., Dacremont G. Studies on the substrate specificity of the inducible and non-inducible acyl-CoA oxidases from rat kidney peroxisomes. J. Biochem. 1993, 113:577-582.
99. Carrozzo R., Bellini C., Lucioli S., Deodato F., Cassandrini D., Cassanello M., Caruso U., Rizzo C., Rizza T., Napolitano M.L., Wanders R.J.A., Jakobs C., Bruno C., Santorelli F.M., Dionisi-Vici C., Bonioli E. Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am. J. Med. Genet. A 2008, 146A:1676-1681.
100. Ferdinandusse S., Barker S., Lachlan K., Duran M., Waterham H.R., Wanders R.J.A., Hammans S. Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy. J. Neurol. Neurosurg. Psychiatry 2010, 81:310-312.
101. Wanders R.J.A., van Roermund C.W.T., Brul S., Schutgens R.B.H., Tager J.M. Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis. J. Inherit. Metab. Dis. 1992, 15:385-388.
102. Ferdinandusse S., Denis S., Mooyer P.A., Dekker C., Duran M., Soorani-Lunsing R.J., Boltshauser E., Macaya A., Gartner J., Majoie C.B., Barth P.G., Wanders R.J.A., BT P.-T. Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann. Neurol. 2006, 59:92-104.
103. Lines M.A., Jobling R., Brady L., Marshall C.R., Scherer S.W., Rodriguez A.R., Lee L., Lang A.E., Mestre T.A., Wanders R.J.A., Ferdinandusse S., Tarnopolsky M.A. Peroxisomal D-bifunctional protein deficiency: three adults diagnosed by whole-exome sequencing. Neurology 2014, 82:963-968.
104. Lieber D.S., Hershman S.G., Slate N.G., Calvo S.E., Sims K.B., Schmahmann J.D., Mootha V.K. Next generation sequencing with copy number variant detection expands the phenotypic spectrum of HSD17B4-deficiency. BMC Med. Genet. 2014, 15:30.
105. Pierce S.B., Walsh T., Chisholm K.M., Lee M.K., Thornton A.M., Fiumara A., Opitz J.M., Levy-Lahad E., Klevit R.E., King M.C. Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault syndrome. Am. J. Hum. Genet. 2010, 87:282-288.
106. Ferdinandusse S., Ylianttila M.S., Gloerich J., Koski M.K., Oostheim W., Waterham H.R., Hiltunen J.K., Wanders R.J.A., Glumoff T. Mutational spectrum of D-bifunctional protein deficiency and structure based genotype-phenotype analysis. Am. J. Hum. Genet. 2006, 78:112-124.
107. Ferdinandusse S., Kostopoulos P., Denis S., Rusch H., Overmars H., Dillmann U., Reith W., Haas D., Wanders R.J.A., Duran M., Marziniak M. Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am. J. Hum. Genet. 2006, 78:1046-1052.
108. Seedorf U., Brysch P., Engel T., Schrage K., Assmann G. Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with intrinsic sterol carrier and lipid transfer activity. J. Biol. Chem. 1994, 269:21277-21283.
109. Wanders R.J.A., Denis S., van Berkel E., Wouters F., Wirtz K.W.A., Seedorf U. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders. J. Inherit. Metab. Dis. 1998, 21:302-305.
110. Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E., Allen J.T., Mclean B.N., Brown A.Y., Vreken P., Waterham H.R., Wanders R.J.A. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat. Genet. 2000, 24:188-191.
111. Schmitz W., Albers C., Fingerhut R., Conzelmann E. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur. J. Biochem. 1995, 231:815-822.
112. Setchell K.D., Heubi J.E., Bove K.E., O'Connell N.C., Brewsaugh T., Steinberg S.J., Moser A., Squires R.H. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology 2003, 124:217-232.
113. Van Veldhoven P.P., Meyhi E., Squires R.H., Fransen M., Fournier B., Brys V., Bennett M.J., Mannaerts G.P. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency. Eur. J. Clin. Investig. 2001, 31:714-722.
114. Haugarvoll K., Johansson S., Tzoulis C., Haukanes B.I., Bredrup C., Neckelmann G., Boman H., Knappskog P.M., Bindoff L.A. MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet. J. Rare Dis. 2013, 8:1-10.
115. Smith E.H., Gavrilov D.K., Oglesbee D., Freeman W.D., Vavra M.W., Matern D., Tortorelli S. An adult onset case of alpha-methyl-acyl-CoA racemase deficiency. J. Inherit. Metab. Dis. 2010.
116. Clarke C.E., Alger S., Preece M.A., Burdon M.A., Chavda S., Denis S., Ferdinandusse S., Wanders R.J.A. Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Neurology 2004, 63:188-189.
117. Thompson S.A., Calvin J., Hogg S., Ferdinandusse S., Wanders R.J.A., Barker R.A. Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. J. Neurol. Neurosurg. Psychiatry 2008, 79:448-450.
118. Van Veldhoven P.P., Meyhi E., Squires R.H., Fransen M., Fournier B., Brys V., Bennett M.J., Mannaerts G.P. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency. Eur. J. Clin. Investig. 2001, 31:714-722.
119. Jansen G.A., Ferdinandusse S., Hogenhout E.M., Verhoeven N.M., Jakobs C., Wanders R.J.A. Phytanoyl-CoA hydroxylase deficiency. Enzymological and molecular basis of classical refsum disease. Adv. Exp. Med. Biol. 1999, 466:371-376.
120. Jansen G.A., Ofman R., Ferdinandusse S., IJlst L., Muijsers A.O., Skjeldal O.H., Stokke O., Jakobs C., Besley G.T., Wraith J.E., Wanders R.J.A. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat. Genet. 1997, 17:190-193.
121. Jansen G.A., Waterham H.R., Wanders R.J.A. Molecular basis of refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum. Mutat. 2004, 23:209-218.
122. Mihalik S.J., Morrell J.C., Kim D., Sacksteder K.A., Watkins P.A., Gould S.J. Identification of PAHX, a Refsum disease gene. Nat. Genet. 1997, 17:185-189.
123. van den Brink D.M., Brites P., Haasjes J., Wierzbicki A.S., Mitchell J., Lambert-Hamill M., de Belleroche J., Jansen G.A., Waterham H.R., Wanders R.J.A. Identification of PEX7 as the second gene involved in refsum disease. Am. J. Hum. Genet. 2003, 72:471-477.
124. Wierzbicki A.S. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review. Biochem. Soc. Trans. 2007, 35:881-886.
125. Wanders R.J.A., Waterham H.R., Leroy B. Refsum Disease. Gene Rev. 2006, (www.genetests.org).
126. Danpure C.J., Purdue P.E. Primary hyperoxaluria. The Metabolic and Molecular Basis of Inherited Disease 1995, 2385-2426. McGraw-Hill. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
127. Danpure C.J., Jennings P.R. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett. 1986, 201:20-24.
128. Cramer S.D., Ferree P.M., Lin K., Milliner D.S., Holmes R.P. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum. Mol. Genet. 1999, 8:2063-2069.
129. Belostotsky R., Seboun E., Idelson G.H., Milliner D.S., Becker-Cohen R., Rinat C., Monico C.G., Feinstein S., Ben-Shalom E., Magen D., Weissman I., Charon C., Frishberg Y. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am. J. Hum. Genet. 2010, 87:392-399.
130. Belostotsky R., Pitt J.J., Frishberg Y. Primary hyperoxaluria type III-a model for studying perturbations in glyoxylate metabolism. J. Mol. Med. 2012, 90:1497-1504. (Berlin, Germany).
131. Barth P.G., Wanders R.J.A., Schutgens R.B.H., Staalman C.R. Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies. Am. J. Med. Genet. 1996, 62:164-168.
132. Motley A.M., Brites P., Gerez L., Hogenhout E.M., Haasjes J., Benne R., Tabak H.F., Wanders R.J.A., Waterham H.R. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am. J. Hum. Genet. 2002, 70:612-624.
133. Heymans H.S.A., Oorthuys J.W., Nelck G., Wanders R.J.A., Schutgens R.B.H. Rhizomelic chondrodysplasia punctata: another peroxisomal disorder. N. Engl. J. Med. 1985, 313:187-188.
134. Wanders R.J.A., Schumacher H., Heikoop J., Schutgens R.B.H., Tager J.M. Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder. J. Inherit. Metab. Dis. 1992, 15:389-391.
135. Itzkovitz B., Jiralerspong S., Nimmo G., Loscalzo M., Horovitz D.D., Snowden A., Moser A., Steinberg S., Braverman N. Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3. Hum. Mutat. 2012, 33:189-197.
136. Wanders R.J.A., Dekker C., Horvath V.A., Schutgens R.B.H., Tager J.M., Van Laer P., Lecoutere D. Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder. J. Inherit. Metab. Dis. 1994, 17:315-318.
137. de Vet E.C., IJlst L., Oostheim W., Dekker C., Moser H.W., van den Bosch H., Wanders R.J.A. Ether lipid biosynthesis. Alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J. Lipid Res. 1999, 40:1998-2003.
138. Honsho M., Asaoku S., Fukumoto K., Fujiki Y. Topogenesis and homeostasis of fatty acyl-CoA reductase 1. J. Biol. Chem. 2013, 288:34588-34598.
139. Ferdinandusse S., Jimenez-Sanchez G., Koster J., Denis S., Van Roermund C.W., Silva-Zolezzi I., Moser A.B., Visser W.F., Gulluoglu M., Durmaz O., Demirkol M., Waterham H.R., Gokcay G., Wanders R.J., Valle D. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. Hum. Mol. Genet. 2015, 24:361-370.
140. Hadzic N., Bull L.N., Clayton P.T., Knisely A.S. Diagnosis in bile acid-CoA: amino acid N-acyltransferase deficiency. World J. Gastroenterol.: WJG 2012, 18:3322-3326.
141. Setchell K.D., Heubi J.E., Shah S., Lavine J.E., Suskind D., Al-Edreesi M., Potter C., Russell D.W., O'Connell N.C., Wolfe B., Jha P., Zhang W., Bove K.E., Knisely A.S., Hofmann A.F., Rosenthal P., Bull L.N. Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology 2013, 144:945-955. (e946; quiz e914-945).
142. Carlton V.E., Harris B.Z., Puffenberger E.G., Batta A.K., Knisely A.S., Robinson D.L., Strauss K.A., Shneider B.L., Lim W.A., Salen G., Morton D.H., Bull L.N. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat. Genet. 2003, 34:91-96.
143. Takahara S. Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases. Lancet 1952, 2:1101-1104.
144. Goth L., Nagy T. Acatalasemia and diabetes mellitus. Arch. Biochem. Biophys. 2012, 525:195-200.
145. Goth L., Nagy T. Inherited catalase deficiency: is it benign or a factor in various age related Disorders?. Mutat. Res. 2013, 753:147-154.
146. Ebberink M.S., Mooijer P.A., Gootjes J., Koster J., Wanders R.J.A., Waterham H.R. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum. Mutat. 2011, 32:59-69.
147. Yik W.Y., Steinberg S.J., Moser A.B., Moser H.W., Hacia J.G. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum. Mutat. 2009, 30:E467-E480.
148. Gould S.J., Raymond G.V., Valle D. The peroxisomal biogenesis disorder. The Metabolic & Molecular Bases of Inherited Disease 2001, 3181-3217. Mc Graw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
149. Poll-The B.T., Saudubray J.M., Ogier H.A., Odievre M., Scotto J.M., Monnens L., Govaerts L.C., Roels F., Cornelis A., Schutgens R.B.H., et al. Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy. Eur. J. Pediatr. 1987, 146:477-483.
150. Kelley R.I., Datta N.S., Dobyns W.B., Hajra A.K., Moser A.B., Noetzel M.J., Zackai E.H., Moser H.W. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am. J. Med. Genet. 1986, 23:869-901.
151. Berendse K., Engelen M., Ferdinandusse S., Majoie C.B., Waterham H.R., Vaz F.M., Koelman J.H., Barth P.G., Wanders R.J., Poll-The B.T. Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J. Inherit. Metab. Dis. 2015.
152. Ebberink M.S., Csanyi B., Chong W.K., Denis S., Sharp P., Mooijer P.A., Dekker C.J., Spooner C., Ngu L.H., De S.C., Wanders R.J.A., Fietz M.J., Clayton P.T., Waterham H.R., Ferdinandusse S. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J. Med. Genet. 2010, 47:608-615.
153. Imamura A., Tsukamoto T., Shimozawa N., Suzuki Y., Zhang Z., Imanaka T., Fujiki Y., Orii T., Kondo K., Osumi T. Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders. Am. J. Hum. Genet. 1998, 62:1539-1543.
154. Regal L., Ebberink M.S., Goemans N., Wanders R.J.A., De M.L., Jaeken J., Schrooten M., Van C.R., Waterham H.R. Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann. Neurol. 2010, 68:259-263.
155. Sevin C., Ferdinandusse S., Waterham H.R., Wanders R.J.A., Aubourg P. Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Orphanet J. Rare Dis. 2011, 6:8.
156. Steinberg S.J., Snowden A., Braverman N.E., Chen L., Watkins P.A., Clayton P.T., Setchell K.D., Heubi J.E., Raymond G.V., Moser A.B., Moser H.W. A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J. Inherit. Metab. Dis. 2009, 32:109-119.
157. Ratbi I., Falkenberg K.D., Sommen M., Al-Sheqaih N., Guaoua S., Vandeweyer G., Urquhart J.E., Chandler K.E., Williams S.G., Roberts N.A., El Alloussi M., Black G.C., Ferdinandusse S., Ramdi H., Heimler A., Fryer A., Lynch S.A., Cooper N., Ong K.R., Smith C.E., Inglehearn C.F., Mighell A.J., Elcock C., Poulter J.A., Tischkowitz M., Davies S.J., Sefiani A., Mironov A.A., Newman W.G., Waterham H.R., Van Camp G. Heimler syndrome is caused by hypomorphic mutations in the peroxisome-biogenesis genes PEX1 and PEX6. Am. J. Hum. Genet. 2015, 97:535-545.
158. Motley A.M., Tabak H.F., Smeitink J.A., Poll-The B.T., Barth P.G., Wanders R.J.A. Non-rhizomelic and rhizomelic chondrodysplasia punctata within a single complementation group. Biochim. Biophys. Acta 1996, 1315:153-158.
159. Baroy T., Koster J., Stromme P., Ebberink M.S., Misceo D., Ferdinandusse S., Holmgren A., Hughes T., Merckoll E., Westvik J., Woldseth B., Walter J., Wood N., Tvedt B., Stadskleiv K., Wanders R.J., Waterham H.R., Frengen E. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum. Mol. Genet. 2015, 24:5845-5854.
160. Shamseldin H.E., Alshammari M., Al-Sheddi T., Salih M.A., Alkhalidi H., Kentab A., Repetto G.M., Hashem M., Alkuraya F.S. Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. J. Med. Genet. 2012, 49:234-241.
161. Huber N., Guimaraes S., Schrader M., Suter U., Niemann A. Charcot-Marie-Tooth disease-associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission. EMBO Rep. 2013, 14:545-552.
162. Hashimoto K., Kato Z., Nagase T., Shimozawa N., Kuwata K., Omoya K., Li A., Matsukuma E., Yamamoto Y., Ohnishi H., Tochio H., Shirakawa M., Suzuki Y., Wanders R.J.A., Kondo N. Molecular mechanism of a temperature-sensitive phenotype in peroxisomal biogenesis disorder. Pediatr. Res. 2005, 58:263-269.
163. Imamura A., Shimozawa N., Suzuki Y., Zhang Z., Tsukamoto T., Fujiki Y., Orii T., Osumi T., Wanders R.J.A., Kondo N. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1. Pediatr. Res. 2000, 48:541-545.
164. Imamura A., Tamura S., Shimozawa N., Suzuki Y., Zhang Z., Tsukamoto T., Orii T., Kondo N., Osumi T., Fujiki Y. Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. Hum. Mol. Genet. 1998, 7:2089-2094.
165. Gootjes J., Schmohl F., Mooijer P.A., Dekker C., Mandel H., Topcu M., Huemer M., von Schutz M., Marquardt T., Smeitink J.A.M., Waterham H.R., Wanders R.J.A. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism. Hum. Mutat. 2004, 24:130-139.
166. Vreken P., Van Lint A.E.M., Bootsma A.H., Overmars H., Wanders R.J.A., Van Gennip A.H. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J. Chromatogr. 1998, 713:281-287.
167. Bootsma A.H., Overmars H., van Rooij A., Van Lint A.E.M., Wanders R.J.A., Van Gennip A.H., Vreken P. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders. J. Inherit. Metab. Dis. 1999, 22:307-310.
168. Dacremont G., Vincent G. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J. Inherit. Metab. Dis. 1995, 18(Suppl. 1):84-89.
169. Ofman R., Wanders R.J.A. Purification of peroxisomal acyl-CoA: dihydroxyacetonephosphate acyltransferase from human placenta. Biochim. Biophys. Acta 1994, 1206:27-34.
170. Wanders R.J.A., Denis S., Ruiter J.P.N., Schutgens R.B.H., van Roermund C.W.T., Jakobs B.S. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J. Inherit. Metab. Dis. 1995, 18(Suppl 1):113-124.
171. Wanders R.J.A., van Roermund C.W.T. Studies on phytanic acid alpha-oxidation in rat liver and cultured human skin fibroblasts. Biochim. Biophys. Acta 1993, 1167:345-350.
172. Wanders R.J.A., Dekker C., Ofman R., Schutgens R.B.H., Mooijer P.A.W. Immunoblot analysis of peroxisomal proteins in liver and fibroblasts from patients. J. Inherit. Metab. Dis. 1995, 18(Suppl. 1):101-112.
173. Wanders R.J.A., Wiemer E.A., Brul S., Schutgens R.B.H., van den Bosch H., Tager J.M. Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J. Inherit. Metab. Dis. 1989, 12(Suppl 2):301-304.
174. Krause C., Rosewich H., Gartner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur. J. Hum. Genet. 2009, 17:741-748.